Avience Biomedicals (NSE:AVIENCE) PB Ratio: 7.98 (As of Jun. 29, 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals PB Ratio?

Avience Biomedicals NSE:AVIENCE 5 PB Ratio is 7.98 as of Jun. 29, 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100. Among 786 Medical Devices & Instruments companies, Avience Biomedicals ranks worse than 127226.34% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), Avience Biomedicals's share price is ₹414.95. Avience Biomedicals's Book Value per Share for the quarter that ended in Jan. 2026 was ₹51.99. Hence, Avience Biomedicals's PB Ratio of today is 7.98.

The historical rank and industry rank for Avience Biomedicals's PB Ratio or its related term are showing as below:

NSE:AVIENCE's PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.015
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Avience Biomedicals  (NSE:AVIENCE) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Avience Biomedicals PB Ratio Related Terms


Avience Biomedicals PB Ratio Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals PB Ratio Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
PB Ratio
0.00 0.00 0.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
PB Ratio 0.00 0.00 0.00 0.00

NSE:AVIENCE vs ABT, SYK, MDT: PB Ratio Comparison

For the Medical Devices subindustry, Avience Biomedicals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avience Biomedicals PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Avience Biomedicals's PB Ratio falls into.


NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Avience Biomedicals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jan. 2026)
=414.95/51.99
=7.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 7.98 mean?
Avience Biomedicals (NSE:AVIENCE) has a PB Ratio of 7.98 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Avience Biomedicals and its competitors. According to the industry distribution chart, Avience Biomedicals ranks #999999 out of 786 companies in the Medical Devices & Instruments industry.
Is Avience Biomedicals' PB Ratio too high?
Avience Biomedicals' current PB Ratio is 7.98. The Medical Devices & Instruments industry median PB Ratio is 2.02. Avience Biomedicals' value of 7.98 is 296% above this industry median. Based on the distribution chart, Avience Biomedicals ranks #999999 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #999999 out of 786 companies for PB Ratio. This places Avience Biomedicals in the lower half of its industry. The industry median PB Ratio is 2.02. Avience Biomedicals' value of 7.98 is 296% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avience Biomedicals's current PB Ratio of 7.98 is 296% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current PB Ratio is 7.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current PB Ratio of 7.98. The current PB Ratio is 7.98 and 296% above the Medical Devices & Instruments industry median of 2.02. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current PB Ratio is 7.98 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price